Key Points Question What is the effectiveness of respiratory syncytial virus (RSV) vaccines against RSV-associated outcomes for US Medicare beneficiaries aged 65 years or older who resided in nursing homes during September 2023 to March 2024?
Ryan Wiegand
Atlanta
As seen in:
Center for Disease Control and Prevention,
Emerging Infectious Diseases Journal,
Nature,
Wiley Online Library,
JAMA (The Journal of the American Medical Association),
JAMA Network,
JAMA: Journal of the American Medical Association,
Medscape,
The Lancet,
Dialnet - Universidad de La Rioja
and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Ryan
Contact Ryan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack